Replies to post #11761 on Momenta Pharmaceuticals, Inc. (MNTA)

[pollyvonwog]

That $75m ATM is still future dillution. Shea hinted that they intended to use it at a higher post m-copax price which is fine I guess so long as they stick to that. The likely scenario on the SCOTUS case is they come out okay one way or another, but how many times have we been here with MNTA in that regard where the unlikely and negative scenario prevails. I think that uncertainty and the fact they won't touch copax revenues added to the dip.I agree with your assessment that M-copax approval is a near term event.